William R. Larue - 26 Jul 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 Jul 2021
Net transactions value
+$25,002
Form type
4
Filing time
27 Jul 2021, 06:00:14 UTC
Previous filing
24 Jun 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $25,002 +6,545 +489% $3.82 7,883 26 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 7, 2019, the Issuer effected a 10 for 1 reverse split of its common stock, upon which the reporting person's ownership was reduced by 12,050 shares of common stock.